ATE269844T1 - Aminobenzophenones als inhibitoren von interleukin und tnf - Google Patents

Aminobenzophenones als inhibitoren von interleukin und tnf

Info

Publication number
ATE269844T1
ATE269844T1 AT98900270T AT98900270T ATE269844T1 AT E269844 T1 ATE269844 T1 AT E269844T1 AT 98900270 T AT98900270 T AT 98900270T AT 98900270 T AT98900270 T AT 98900270T AT E269844 T1 ATE269844 T1 AT E269844T1
Authority
AT
Austria
Prior art keywords
alkyl
content
carbamoyl
alkoxycarbonyl
trifluoromethyl
Prior art date
Application number
AT98900270T
Other languages
German (de)
English (en)
Inventor
Erik Rytter Ottosen
Schneur Rachlin
Original Assignee
Leo Pharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharma As filed Critical Leo Pharma As
Application granted granted Critical
Publication of ATE269844T1 publication Critical patent/ATE269844T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/22—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT98900270T 1997-01-24 1998-01-08 Aminobenzophenones als inhibitoren von interleukin und tnf ATE269844T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9701453.4A GB9701453D0 (en) 1997-01-24 1997-01-24 Aminobenzophenones
PCT/DK1998/000008 WO1998032730A1 (en) 1997-01-24 1998-01-08 Aminobenzophenones as inhibitors of interleukin and tnf

Publications (1)

Publication Number Publication Date
ATE269844T1 true ATE269844T1 (de) 2004-07-15

Family

ID=10806523

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98900270T ATE269844T1 (de) 1997-01-24 1998-01-08 Aminobenzophenones als inhibitoren von interleukin und tnf

Country Status (19)

Country Link
US (1) US6313174B1 (cg-RX-API-DMAC10.html)
EP (1) EP0966424B1 (cg-RX-API-DMAC10.html)
JP (1) JP4250204B2 (cg-RX-API-DMAC10.html)
KR (1) KR100544046B1 (cg-RX-API-DMAC10.html)
CN (1) CN1188388C (cg-RX-API-DMAC10.html)
AT (1) ATE269844T1 (cg-RX-API-DMAC10.html)
AU (1) AU733561B2 (cg-RX-API-DMAC10.html)
CA (1) CA2278798C (cg-RX-API-DMAC10.html)
DE (1) DE69824705T2 (cg-RX-API-DMAC10.html)
DK (1) DK0966424T3 (cg-RX-API-DMAC10.html)
ES (1) ES2223116T3 (cg-RX-API-DMAC10.html)
GB (1) GB9701453D0 (cg-RX-API-DMAC10.html)
HU (1) HUP0000678A3 (cg-RX-API-DMAC10.html)
NZ (1) NZ336754A (cg-RX-API-DMAC10.html)
PL (1) PL334806A1 (cg-RX-API-DMAC10.html)
PT (1) PT966424E (cg-RX-API-DMAC10.html)
RO (1) RO120195B1 (cg-RX-API-DMAC10.html)
RU (1) RU2200153C2 (cg-RX-API-DMAC10.html)
WO (1) WO1998032730A1 (cg-RX-API-DMAC10.html)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE277889T1 (de) * 1999-07-16 2004-10-15 Leo Pharma As Aminobenzophenone als inhibitoren von il-1beta und tnf-alpha
KR20020022774A (ko) * 1999-07-16 2002-03-27 룬딩 에른스트 IL-1β 및 TNF-α 억제제로서의 아미노벤조페논
PT1210320E (pt) * 1999-07-16 2005-01-31 Leo Pharma As Aminobenzofenonas como inibidores de il-1beta e tnf-alfa
RU2247719C2 (ru) * 1999-07-16 2005-03-10 Лео Фармасьютикал Продактс Лтд.А/С (Левенс Кемиске Фабрик Продукционсактиесельскаб) Аминобензофеноны как ингибиторы il-1 бета и tnf-альфа, фармацевтическая композиция и способ лечения и/или профилактики воспалительных заболеваний
ES2204639T3 (es) * 1999-07-16 2004-05-01 Leo Pharma A/S Nuevas aminobenzofeonas.
US6897236B1 (en) 1999-07-16 2005-05-24 Leo Pharmaceutical Products, Ltd. Aminobenzophenones as inhibitors of IL-1β and TNF-α
KR20020071876A (ko) * 1999-12-06 2002-09-13 레오 파마 에이/에스 IL-1β 및 TNF-α의 억제제로서의 아미노벤조페논
CA2393027A1 (en) * 1999-12-17 2001-06-21 Abbott Laboratories Inhibitors of interleukin 5 gene expression
CA2396693A1 (en) * 1999-12-28 2001-07-05 Stephen T. Wrobleski Cytokine, especially tnf-alpha, inhibitors
CN1239485C (zh) * 2000-05-22 2006-02-01 里奥制药有限公司 作为IL-1β和TNF-α抑制剂的二苯酮类
US20020165286A1 (en) * 2000-12-08 2002-11-07 Hanne Hedeman Dermal anti-inflammatory composition
SE0100569D0 (sv) * 2001-02-20 2001-02-20 Astrazeneca Ab New compounds
GB0107368D0 (en) * 2001-03-23 2001-05-16 Novartis Ag Organic compounds
US20030073832A1 (en) * 2001-04-10 2003-04-17 Havez Sophie Elisabeth Novel aminophenyl ketone derivatives
JP4540984B2 (ja) * 2001-08-28 2010-09-08 レオ ファーマ アクティーゼルスカブ 新規アミノベンゾフェノン
RU2005122951A (ru) * 2002-12-20 2006-01-27 Лео Фарма А/С (Dk) Новые аминобензофеноновые соединения
RU2396250C2 (ru) 2003-07-24 2010-08-10 Лео Фарма А/С Новые производные аминобензофенона
EP1828148B1 (en) 2004-12-13 2010-01-20 Leo Pharma A/S Triazole substituted aminobenzophenone compounds
DE102005022020A1 (de) * 2005-05-12 2006-11-23 Merckle Gmbh Dibenzocycloheptanverbindungen und pharmazeutische Mittel, welche diese Verbindungen enthalten
KR101057546B1 (ko) * 2007-06-05 2011-08-17 주식회사 엘지화학 광학 이방성 화합물 및 이를 포함하는 수지 조성물
EP2206534A1 (de) 2008-10-09 2010-07-14 c-a-i-r biosciences GmbH Dibenzocycloheptanonderivate und pharmazeutische Mittel, welche diese Verbindungen enthalten
WO2012167133A2 (en) * 2011-06-01 2012-12-06 The Regents Of The University Of California Inhibitors of anandamide transport and their therapeutic uses
JP6092870B2 (ja) 2011-08-19 2017-03-08 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア メタ置換ビフェニル末梢に限局されたfaah阻害剤
ES2908240T3 (es) 2014-04-07 2022-04-28 Univ California Inhibidores de la enzima amida hidrolasa de ácidos grasos (FAAH) con biodisponibilidad oral mejorada y su uso como medicamentos

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1535401A (en) * 1977-07-28 1978-12-13 Holliday & Co Ltd L Nitrodiphenylamine carboxylic acid disperse dyes
SU790620A1 (ru) * 1979-06-01 1981-07-30 Ордена Трудового Красного Знамени Институт Медицинскойпаразитологии И Торпической Медицины Им.E.И.Марциновского Дихлор аминобензофенон как исходный продуктдл пОлучЕНи лЕКАРСТВЕННыХ пРЕпАРАТОВ C АНТигЕльМиНТНыМдЕйСТВиЕМ
JPH0776303B2 (ja) * 1986-11-21 1995-08-16 株式会社リコー 呈色性フタリド化合物及びその製造法及びこのものを発色成分とした記録材料

Also Published As

Publication number Publication date
JP4250204B2 (ja) 2009-04-08
DE69824705D1 (de) 2004-07-29
CN1188388C (zh) 2005-02-09
JP2001511771A (ja) 2001-08-14
KR100544046B1 (ko) 2006-01-23
AU5478198A (en) 1998-08-18
NZ336754A (en) 2001-03-30
KR20000070437A (ko) 2000-11-25
DE69824705T2 (de) 2005-07-07
HUP0000678A3 (en) 2001-11-28
EP0966424B1 (en) 2004-06-23
RU2200153C2 (ru) 2003-03-10
EP0966424A1 (en) 1999-12-29
HUP0000678A2 (hu) 2001-10-28
PT966424E (pt) 2004-09-30
RO120195B1 (ro) 2005-10-28
AU733561B2 (en) 2001-05-17
CA2278798A1 (en) 1998-07-30
HK1025306A1 (en) 2000-11-10
PL334806A1 (en) 2000-03-13
WO1998032730A1 (en) 1998-07-30
CN1248966A (zh) 2000-03-29
US6313174B1 (en) 2001-11-06
DK0966424T3 (da) 2004-11-01
GB9701453D0 (en) 1997-03-12
CA2278798C (en) 2007-07-03
ES2223116T3 (es) 2005-02-16

Similar Documents

Publication Publication Date Title
DE69824705D1 (de) Aminobenzophenones als inhibitoren von interleukin und tnf
ATE420644T1 (de) Kondensierte azabicyclischeverbindungen als inhibitoren des vanilloid-rezeptors 1 (vr1)
TR199801777T2 (xx) Triaril bile�ikler.
MY158162A (en) 5-membered heterocycle-based p38 kinase inhibitors
ATE187447T1 (de) 3-phenyl-2-isoxazoline derivate als entzündugshemmende mittel
MXPA05013075A (es) Inhibidores de p-38 basados en heterociclo de 5 miembros.
MXPA05013224A (es) Piridinilcarbamatos como inhibidores de lipasa sensible a hormonas.
DE60315146D1 (de) Heteroarylsubstituierte biphenylderivate als inhibitoren von p38-kinase
ATE154932T1 (de) Isoxazolinverbindungen als entzündungshemmende mittel
MY135856A (en) Nicotinamide derivatives useful as pde4 inhibitors
CY1116754T1 (el) Παραγωγα νιτροκατεχολης ως αναστολεις της comt
ATE511840T1 (de) Imidazolderivate als entzündungshemmende mittel
ATE457313T1 (de) Bicyclische heterocyclische p-38-kinase- inhibitoren
RU95113454A (ru) Катехольные диэфиры как селективные ингибиторы фдэiv, фармацевтическая композиция, способы лечения
YU6602A (sh) Pirimidin-2,4,6-trion metaloproteinazni inhibitori
ATE529406T1 (de) Aryl-harnstoffe als kinase inhibitoren
ATE246184T1 (de) Chinoline und deren therapeutische verwendung
TR199901917T2 (xx) 2-Amino-6-(2-ikame edilmi�-4-fenoksi)-ikame edilmi� piridinler
ES2195785A1 (es) Nuevos derivados de piridazin-3(2h)-ona.
ATE305787T1 (de) 3,4-dihydro-(1h)chinazolin-2-on-verbindungen als csbp/p39-kinase-inhibitoren
MXPA02011858A (es) Inhibidores de adhesion de celula mediada por alfabeta2.
SE0302756D0 (sv) Novel Compounds
AP2000001761A0 (en) Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase.
DE50211985D1 (de) Verwendung von pyridin-2,4-dicarbons urediamiden und pyrimid in-4,6-dicarbons urediamiden zur selektiven inhibierung von kollagenasen
EP1575497A4 (en) NEW COMPOSITION AND METHOD FOR TREATING PSORIASIS

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0966424

Country of ref document: EP